Claims for Patent: 7,666,628

Summary for Patent: 7,666,628

Title:	Preparation of heterologous proteins on oil bodies
Abstract:	The present invention relates to the use of a class of genes called oil body protein genes that have unique features. The discovery of these features allowed the invention of methods for the production of recombinant proteins wherein a protein of interest can be easily separated from other host cell components. The invention is further exemplified by methods for exploitation of the unique characteristics of the oil body proteins and oil body genes for expression of polypeptides of interest in many organisms, particularly plant seeds. Said polypeptides may include but are not limited to: seed storage proteins, enzymes, bioactive peptides, antibodies and the like. The invention can also be modified to recover recombinant polypeptides fused to oil body proteins from non-plant host cells. Additionally the invention provides a method of using recombinant proteins associated with seed oil bodies released during seed germination for expression of polypeptides that afford protection to seedlings from pathogens. Finally, the persistent association of oil body proteins with the oil body can be further utilized to develop a biological means to create novel immobilized enzymes useful for bioconversion of substrates.
Inventor(s):	Moloney; Maurice M. (Calgary, CA), Van Rooijen; Gijs (Calgary, CA)
Assignee:	SemBioSys Genetics Inc. (Calgary, Alberta, CA)
Application Number:	10/763,380
Patent Claims:	1. A method for the expression of a heterologous polypeptide by a host cell said method comprising: a) introducing into a host cell a chimeric nucleic acid sequence comprising: 1) a first nucleic acid sequence capable of regulating the transcription in said host cell of 2) a second nucleic acid sequence, wherein said second sequence encodes a fusion polypeptide and comprises (i) a) a nucleic acid sequence encoding an oleosin protein having the amino acid sequence shown in SEQ ID NO:2 or SEQ ID NO:5 or b) a nucleic acid encoding a caleosin protein and having the nucleic acid sequence shown in SEQ ID NO:34 or SEQ ID NO:35 to provide targeting of the fusion polypeptide to a lipid phase linked in reading frame to (ii) a nucleic acid sequence encoding the heterologous polypeptide; and 3) a third nucleic acid sequence encoding a termination region functional in the host cell; and b) growing said host cell to produce the fusion polypeptide. 2. The method according to claim 1 further including separating the recombinant fusion polypeptide from cellular host cell components by selective partitioning into a lipid phase. 3. The method according to claim 2 wherein said selective partitioning comprises centrifugation, floatation or size exclusion. 4. The method according to claim 1 further including separating the recombinant fusion polypeptide from cellular host components by selective partitioning into a lipid phase comprising oil bodies. 5. The method according to claim 4 wherein said recombinant fusion polypeptide is separated by addition of oil body components and reconstitution of the oil bodies. 6. The method according to claim 2 further comprising releasing the heterologous polypeptide from the fusion polypeptide associated with the lipid phase, said method comprising: c) including in said second nucleic acid sequence (2) between said nucleic acid sequence (i) encoding the oil body protein and the nucleic acid sequence (ii) encoding the heterologous polypeptide, a linker nucleic acid sequence (iii) encoding an amino acid sequence that is specifically cleavable by enzymatic or chemical means; and d) contacting the lipid phase with said enzymatic or chemical means such that said heterologous polypeptide is released from the fusion polypeptide. 7. The method according to claim 6 wherein said linker nucleic acid sequence encodes an amino acid sequence that is recognizable by the proteolytic action of an enzyme selected from the group consisting of thrombin, factor Xa, collagenase, chymosin, clostrapain and viral protease. 8. The method according to claim 6 wherein said enzymatic means comprises an enzyme that is immobilized. 9. The method according to claim 8 wherein said enzyme is immobilized by attachment to an oil body protein that is associated with an oil body. 10. The method according to claim 1 wherein said recombinant polypeptide is an enzyme. 11. The method according to claim 10 wherein said recombinant polypeptide is an enzyme that retains its enzymatic properties while part of the fusion polypeptide is associated with the oil body. 12. A method of preparing an enzyme in a host cell in association with an oil body and releasing said enzyme from the oil body, said method comprising: a) transforming a host cell with a chimeric nucleic acid sequence comprising: 1) a first nucleic acid sequence capable of regulating the transcription of 2) a second nucleic acid sequence, wherein said second sequence encodes a fusion polypeptide and comprises (i) a) a nucleic acid sequence encoding an oleosin protein having the amino acid sequence shown in SEQ ID NO:2 or SEQ ID NO:5 or b) a nucleic acid encoding a caleosin protein and having the nucleic acid sequence shown in SEQ ID NO:34 or SEQ ID NO:35 to provide targeting of the fusion polypeptide to an oil body; (ii) a nucleic acid sequence encoding an enzyme and (iii) a linker nucleic acid sequence located between said nucleic acid sequence (i) encoding the oleosin or caleosin protein and said nucleic acid sequence (ii) encoding the enzyme and encoding an amino acid sequence that is cleavable by the enzyme encoded by the nucleic acid sequence (ii); and 3) a third nucleic acid sequence encoding a termination region functional in said host cell b) growing the host cell to produce the fusion polypeptide under conditions such that enzyme is not active; c) recovering the oil bodies containing the fusion polypeptide; and d) altering the environment of the oil bodies such that the enzyme is activated and cleaves itself from the fusion polypeptide. 13. The method according to claim 12 wherein said enzyme is activated by lowering the pH or altering the temperature of the oil body environment. 14. The method according to claim 1 wherein said heterologous polypeptide is selected from the group consisting of antibodies, glycanases, hormones, proteases, protease inhibitors and seed storage proteins. 15. The method according to claim 1 wherein said heterologous polypeptide is selected from the group consisting of a thrombin inhibitor, hirudin, an interleukin, chymosin, cystatin, xylanase, carp growth hormone, zein, an antibody and a collagenase. 16. The method according to claim 1 wherein said host cell is an insect or animal cell. 17. A method according to claim 1 wherein said nucleic acid sequence (i) encodes an oleosin and has the nucleic acid sequence shown in SEQ ID NO:1 or SEQ ID NO:4. 18. A method for the expression of a heterologous polypeptide by a host cell said method comprising: a) generating by homologous recombination into a host cell a chimeric nucleic acid sequence comprising: 1) a first nucleic acid sequence capable of regulating transcription in said host cell 2) a second nucleic acid sequence, wherein said second sequence encodes a fusion polypeptide and comprises (i) a) a nucleic acid sequence encoding an oleosin protein having the amino acid sequence shown in SEQ ID NO:2 or SEQ ID NO:5 or b) a nucleic acid encoding a caleosin protein and having the nucleic acid sequence shown in SEQ ID NO:34 or SEQ ID NO:35 to provide targeting of the fusion polypeptide to a lipid phase, linked in reading frame to (ii) a nucleic acid sequence encoding the heterologous polypeptide; and 3) a third nucleic acid sequence encoding a termination region functional in the host cell; and b) growing said host cell to produce the heterologous polypeptide. 19. A chimeric nucleic acid sequence, capable of being expressed in association with an oil body of a host cell comprising: 1) a first nucleic acid sequence capable of regulating the transcription in said host cell of 2) a second nucleic acid sequence, wherein said second sequence encodes a fusion polypeptide and comprises (i) a) a nucleic acid sequence encoding an oleosin protein having the amino acid sequence shown in SEQ ID NO:2 or SEQ ID NO:5 or b) a nucleic acid encoding a caleosin protein and having the nucleic acid sequence shown in SEQ ID NO:34 or SEQ ID NO:35 to provide targeting of the fusion polypeptide to a lipid phase linked in reading frame to (ii) a nucleic acid sequence encoding the heterologous polypeptide; and 3) a third nucleic acid sequence encoding a termination region functional in the host cell. 20. The chimeric nucleic acid sequence according to claim 19 wherein said nucleic acid sequence (ii) encodes an enzyme. 21. The chimeric nucleic acid sequence according to claim 19 further including (iii) a linker nucleic acid sequence encoding an amino acid sequence that is specifically cleavable by enzymatic means wherein said linker nucleic acid sequence (iii) is located between said (i) nucleic acid sequence encoding the oil body protein and said (ii) nucleic acid sequence encoding the heterologous polypeptide. 22. The chimeric nucleic acid according to claim 21 wherein said linker nucleic acid sequence (iii) encodes a cleavage site for an enzyme selected from the group consisting of thrombin, factor Xa, collagenase chymosin and viral protease. 23. A chimeric nucleic acid sequence according to claim 19 wherein said nucleic acid sequence (i) encodes an oleosin and has the nucleic acid sequence shown in SEQ ID NO:1 or SEQ ID NO:4. 24. An expression cassette comprising a chimeric nucleic acid sequence according to claim 19.

Details for Patent 7,666,628

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2011-02-22